Latest return on equity
IRulya Therapeutics Return on equity
Direct answer
IRulya Therapeutics's return on equity is -153.84%.
The verified market snapshot reports -153.84%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free IRulya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -153.84%